<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to determine the molecular genetic alterations associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion, Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and its non-invasive precursor lesions were investigated by comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), and loss of heterozygosity (LOH) </plain></SENT>
<SENT sid="1" pm="."><plain>Along the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence in Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> gains on 7q, 8q, 20q, 2p, 10q and 17q, and losses on Y, 4q, 5q, 9p 18q and 14q became steadily more frequent </plain></SENT>
<SENT sid="2" pm="."><plain>FISH demonstrated increasing DNA copy of numbers of c-erbB-2, 20q13.2 (<z:chebi fb="165" ids="27971">AIB</z:chebi>), c-myc and cyclin D1 during the development of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, and LOH confirmed DNA losses on 5q21 (APC) and 18q (<z:chebi fb="8" ids="53090">DCC</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>Some of the chromosomal changes of the non-invasive precursor lesions were significantly different from the alterations detected in invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Although molecular pathology may be used as diagnostic adjunct in future, the histopathological determination of invasion remains the most important diagnostic criterion of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>